Marshall Wace’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91K | Buy |
+68,454
| New | +$91K | ﹤0.01% | 2407 |
|
|
2025
Q1 | – | Sell |
-39,024
| Closed | -$63.6K | – | 2800 |
|
|
2024
Q4 | $63.6K | Buy |
39,024
+10,837
| +38% | +$17.7K | ﹤0.01% | 2299 |
|
|
2024
Q3 | $108K | Buy |
+28,187
| New | +$108K | ﹤0.01% | 2191 |
|
|
2024
Q2 | – | Sell |
-41,221
| Closed | -$163K | – | 2592 |
|
|
2024
Q1 | $163K | Buy |
+41,221
| New | +$163K | ﹤0.01% | 1984 |
|
|
2023
Q4 | – | Sell |
-68,795
| Closed | -$347K | – | 2174 |
|
|
2023
Q3 | $347K | Sell |
68,795
-4,425
| -6% | -$22.3K | ﹤0.01% | 1539 |
|
|
2023
Q2 | $368K | Sell |
73,220
-65,788
| -47% | -$331K | ﹤0.01% | 1670 |
|
|
2023
Q1 | $855K | Buy |
139,008
+103,376
| +290% | +$636K | ﹤0.01% | 1477 |
|
|
2022
Q4 | $470K | Buy |
35,632
+8,034
| +29% | +$106K | ﹤0.01% | 1836 |
|
|
2022
Q3 | $82K | Sell |
27,598
-49,147
| -64% | -$146K | ﹤0.01% | 2435 |
|
|
2022
Q2 | $281K | Sell |
76,745
-93,734
| -55% | -$343K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $1.06M | Buy |
170,479
+101,550
| +147% | +$629K | ﹤0.01% | 1840 |
|
|
2021
Q4 | $557K | Buy |
68,929
+10,756
| +18% | +$86.9K | ﹤0.01% | 2117 |
|
|
2021
Q3 | $867K | Buy |
+58,173
| New | +$867K | ﹤0.01% | 1622 |
|
|
2021
Q2 | – | Sell |
-44,232
| Closed | -$201K | – | 2431 |
|
|
2021
Q1 | $201K | Buy |
+44,232
| New | +$201K | ﹤0.01% | 1933 |
|